{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:30:18Z","timestamp":1793831418232,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Clinical Research Plan of SHDC","award":["2020CR4065"],"award-info":[{"award-number":["2020CR4065"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071956"],"award-info":[{"award-number":["82071956"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite the demonstrated adverse outcome, it is difficult to early identify the risks for patients with ischemia and no obstructive coronary artery disease (INOCA). We aimed to explore the prognostic potential of CZT SPECT in INOCA patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study population consisted of a retrospective cohort of 118 INOCA patients, all of whom underwent CZT SPECT imaging and invasive coronary angiography (ICA). Dynamic data were reconstructed, and MBF was quantified using net retention model. Major adverse cardiovascular events (MACEs) were defined as cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, heart failure, late coronary revascularization, or hospitalization for unstable angina.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During a median follow-up of 15 months (interquartile range (IQR) 11\u201320), 19 (16.1%) MACEs occurred; both stress myocardial blood flow (sMBF) (\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$p&lt;0.001$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mrow>\n                              <mml:mi>p<\/mml:mi>\n                              <mml:mo>&lt;<\/mml:mo>\n                              <mml:mn>0.001<\/mml:mn>\n                            <\/mml:mrow>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      ) and coronary flow reserve (CFR) (\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$p&lt;0.001$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mrow>\n                              <mml:mi>p<\/mml:mi>\n                              <mml:mo>&lt;<\/mml:mo>\n                              <mml:mn>0.001<\/mml:mn>\n                            <\/mml:mrow>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      ) were significantly lower in the MACE group. Optimal thresholds of sMBF&lt;3.16 and CFR&lt;2.52 were extracted from the ROC curves, and both impaired sMBF (HR: 15.08; 95% CI 2.95\u201377.07;\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$p=0.001$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mrow>\n                              <mml:mi>p<\/mml:mi>\n                              <mml:mo>=<\/mml:mo>\n                              <mml:mn>0.001<\/mml:mn>\n                            <\/mml:mrow>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      ) and CFR (HR: 6.51; 95% CI 1.43\u201329.65;\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$p=0.01$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mrow>\n                              <mml:mi>p<\/mml:mi>\n                              <mml:mo>=<\/mml:mo>\n                              <mml:mn>0.01<\/mml:mn>\n                            <\/mml:mrow>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      ) were identified as prognostic factors for MACEs. Only sMBF&lt;3.16 (HR: 11.20; 95% CI 2.04\u201361.41;\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$p=0.005$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mrow>\n                              <mml:mi>p<\/mml:mi>\n                              <mml:mo>=<\/mml:mo>\n                              <mml:mn>0.005<\/mml:mn>\n                            <\/mml:mrow>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      ) remained a robust predictor when sMBF and CFR were integrated considered. Compared with CFR, sMBF provides better prognostic model discrimination and reclassification ability (C-index improvement = 0.06,\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$p=0.02$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mrow>\n                              <mml:mi>p<\/mml:mi>\n                              <mml:mo>=<\/mml:mo>\n                              <mml:mn>0.02<\/mml:mn>\n                            <\/mml:mrow>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      ; net reclassification improvement (NRI) = 0.19; integrated discrimination improvement (IDI) = 0.10).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The preliminary results demonstrated that quantitative analysis on CZT SPECT provides prognostic value for INOCA patients, which may allow the stratification for early prevention and intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00259-023-06125-3","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T03:04:30Z","timestamp":1676343870000},"page":"1940-1953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["The prognostic value of CZT SPECT myocardial blood flow (MBF) quantification in patients with ischemia and no obstructive coronary artery disease (INOCA): a pilot study"],"prefix":"10.1007","volume":"50","author":[{"given":"Han","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Caobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuangyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2951-725X","authenticated-orcid":false,"given":"Fei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"key":"6125_CR1","doi-asserted-by":"publisher","unstructured":"Beltrame JF, Tavella R, Jones D, Zeitz C. Management of ischaemia with non-obstructive coronary arteries (INOCA). BMJ.\u00a02021;375:e060602. https:\/\/doi.org\/10.1136\/bmj-2021-060602.","DOI":"10.1136\/bmj-2021-060602"},{"key":"6125_CR2","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","volume":"135","author":"CN Bairey Merz","year":"2017","unstructured":"Bairey Merz CN, Pepine CJ, Walsh MN, Fleg JL, Camici PG, Chilian WM, et al. Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade. Circulation. 2017;135:1075\u201392. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024534.","journal-title":"Circulation."},{"key":"6125_CR3","doi-asserted-by":"publisher","unstructured":"Herscovici R, Sedlak T, Wei J, Pepine CJ, Handberg E, Bairey Merz CN. Ischemia and no obstructive coronary artery disease (INOCA): what is the risk? J Am Heart Assoc.\u00a02018;7(17):e008868. https:\/\/doi.org\/10.1161\/JAHA.118.008868.","DOI":"10.1161\/JAHA.118.008868"},{"issue":"37","key":"6125_CR4","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","volume":"41","author":"V Kunadian","year":"2020","unstructured":"Kunadian V, Camici PG, Berry C, Escaned J, Maas AHEM, Prescott E, et al. An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on coronary pathophysiology & microcirculation endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J. 2020;41(37):3504\u201320. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa503.","journal-title":"Eur Heart J."},{"issue":"8","key":"6125_CR5","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMra061889","volume":"356","author":"PG Camici","year":"2007","unstructured":"Camici PG. Coronary microvascular dysfunction. N Engl J Med. 2007;356(8):830\u201340. https:\/\/doi.org\/10.1056\/NEJMra061889.","journal-title":"N Engl J Med."},{"key":"6125_CR6","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","volume":"78","author":"MG Del Buono","year":"2021","unstructured":"Del Buono MG, Montone RA, Camilli M, Carbone S, Narula J, Lavie CJ, et al. Coronary microvascular dysfunction across the spectrum of cardiovascular diseases. J Am Coll Cardiol. 2021;78:1352\u201371. https:\/\/doi.org\/10.1016\/j.jacc.2021.07.042.","journal-title":"J Am Coll Cardiol."},{"key":"6125_CR7","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/cvr\/cvz339","volume":"116","author":"P Ong","year":"2020","unstructured":"Ong P, Safdar B, Seitz A, Hubert A, Beltrame JF, Prescott E. Diagnosis of coronary microvascular dysfunction in the clinic. Cardiovasc Res. 2020;116:841\u201355. https:\/\/doi.org\/10.1093\/cvr\/cvz339.","journal-title":"Cardiovasc Res."},{"issue":"12","key":"6125_CR8","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.2967\/jnumed.112.107417","volume":"53","author":"L Imbert","year":"2012","unstructured":"Imbert L, Poussier S, Franken PR, Songy B, Verger A, Morel O, et al. Compared performance of high-sensitivity cameras dedicated to myocardial perfusion SPECT: a comprehensive analysis of phantom and human images. J Nucl Med. 2012;53(12):1897\u2013903. https:\/\/doi.org\/10.2967\/jnumed.112.107417.","journal-title":"J Nucl Med."},{"key":"6125_CR9","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1007\/s12350-019-01939-x","volume":"28","author":"R Giubbini","year":"2021","unstructured":"Giubbini R, Bertoli M, Durmo R, Bonacina M, Peli A, Faggiano I, et al. Comparison between N13NH3-PET and 99mTc-Tetrofosmin-CZT SPECT in the evaluation of absolute myocardial blood flow and flow reserve. J Nucl Cardiol. 2021;28:1906\u201318. https:\/\/doi.org\/10.1007\/s12350-019-01939-x.","journal-title":"J Nucl Cardiol."},{"key":"6125_CR10","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00259-019-04644-6","volume":"47","author":"W Acampa","year":"2020","unstructured":"Acampa W, Assante R, Mannarino T, Zampella E, D\u2019Antonio A, Buongiorno P, et al. Low-dose dynamic myocardial perfusion imaging by CZT-SPECT in the identification of obstructive coronary artery disease. Eur J Nucl Med Mol Imaging. 2020;47:1705\u201312. https:\/\/doi.org\/10.1007\/s00259-019-04644-6.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"6125_CR11","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1007\/s12350-020-02129-w","volume":"28","author":"W Acampa","year":"2021","unstructured":"Acampa W, Zampella E, Assante R, Genova A, De Simini G, Mannarino T, et al. Quantification of myocardial perfusion reserve by CZT-SPECT: a head to head comparison with 82Rubidium PET imaging. J Nucl Cardiol. 2021;28:2827\u201339. https:\/\/doi.org\/10.1007\/s12350-020-02129-w.","journal-title":"J Nucl Cardiol."},{"key":"6125_CR12","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00259-018-3958-7","volume":"45","author":"D Agostini","year":"2018","unstructured":"Agostini D, Roule V, Nganoa C, Roth N, Baavour R, Parienti J-J, et al. First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study. Eur J Nucl Med Mol Imaging. 2018;45:1079\u201390. https:\/\/doi.org\/10.1007\/s00259-018-3958-7.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"4","key":"6125_CR13","doi-asserted-by":"publisher","first-page":"e012599","DOI":"10.1161\/CIRCIMAGING.121.01259","volume":"15","author":"KK Patel","year":"2022","unstructured":"Patel KK, Peri-Okonny PA, Qarajeh R, Patel FS, Sperry BW, McGhie AI, et al. Prognostic relationship between coronary artery calcium score, perfusion defects, and myocardial blood flow reserve in patients with suspected coronary artery disease. Circ Cardiovasc Imaging. 2022;15(4):e012599. https:\/\/doi.org\/10.1161\/CIRCIMAGING.121.01259.","journal-title":"Circ Cardiovasc Imaging."},{"issue":"3","key":"6125_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407\u201377. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425.","journal-title":"Eur Heart J."},{"key":"6125_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s12350-015-0387-x","volume":"23","author":"MJ Henzlova","year":"2016","unstructured":"Henzlova MJ, Duvall WL, Einstein AJ, Travin MI, Verberne HJ. ASNC imaging guidelines for SPECT nuclear cardiology procedures: stress, protocols, and tracers. J Nucl Cardiol. 2016;23:606\u201339. https:\/\/doi.org\/10.1007\/s12350-015-0387-x.","journal-title":"J Nucl Cardiol."},{"key":"6125_CR16","doi-asserted-by":"publisher","first-page":"1021326","DOI":"10.3389\/fendo.2022.1021326","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang H, Che W, Shi K, Huang Y, Xu C, Fei M, et al. FT4\/FT3 ratio: A novel biomarker predicts coronary microvascular dysfunction (CMD) in euthyroid INOCA patients. Front Endocrinol. 2022;13:1021326. https:\/\/doi.org\/10.3389\/fendo.2022.1021326.","journal-title":"Front Endocrinol."},{"key":"6125_CR17","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/01.res.65.3.632","volume":"65","author":"JA Leppo","year":"1989","unstructured":"Leppo JA, Meerdink DJ. Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium. Circ Res. 1989;65:632\u20139. https:\/\/doi.org\/10.1161\/01.res.65.3.632.","journal-title":"Circ Res."},{"key":"6125_CR18","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.jcmg.2018.05.021","volume":"12","author":"S Nakamura","year":"2019","unstructured":"Nakamura S, Kitagawa K, Goto Y, Omori T, Kurita T, Yamada A, et al. Incremental prognostic value of myocardial blood flow quantified with stress dynamic computed tomography perfusion imaging. JACC Cardiovasc Imaging. 2019;12:1379\u201387. https:\/\/doi.org\/10.1016\/j.jcmg.2018.05.021.","journal-title":"JACC Cardiovasc Imaging."},{"key":"6125_CR19","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1007\/s00259-018-4046-8","volume":"45","author":"C Gebhard","year":"2018","unstructured":"Gebhard C, Fiechter M, Herzog BA, Lohmann C, Bengs S, Treyer V, et al. Sex differences in the long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography. Eur J Nucl Med Mol Imaging. 2018;45:1964\u201374. https:\/\/doi.org\/10.1007\/s00259-018-4046-8.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"1","key":"6125_CR20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12874-021-01440-5","volume":"21","author":"E Bosco","year":"2021","unstructured":"Bosco E, Hsueh L, McConeghy KW, Gravenstein S, Saade E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Methodol. 2021;21(1):241. https:\/\/doi.org\/10.1186\/s12874-021-01440-5.","journal-title":"BMC Med Res Methodol."},{"key":"6125_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJMoa1002358","volume":"364","author":"GW Stone","year":"2011","unstructured":"Stone GW, Maehara A, Lansky AJ, de Bruyne B, Cristea E, Mintz GS, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226\u201335. https:\/\/doi.org\/10.1056\/NEJMoa1002358.","journal-title":"N Engl J Med."},{"key":"6125_CR22","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMoa1002358","volume":"39","author":"F Radico","year":"2018","unstructured":"Radico F, Zimarino M, Fulgenzi F, Ricci F, Di Nicola M, Jespersen L, et al. Determinants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysis. Eur Heart J. 2018;39:2135\u201346. https:\/\/doi.org\/10.1056\/NEJMoa1002358.","journal-title":"Eur Heart J."},{"key":"6125_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s12350-021-02697-5.10.1007\/s12350-021-02697-5","author":"W Fang","year":"2021","unstructured":"Fang W, Hsu B. Myocardial blood flow quantitation with the SPECT technique: is it ready to be a substitute for PET myocardial blood flow quantitation? J Nucl Cardiol. 2021. https:\/\/doi.org\/10.1007\/s12350-021-02697-5.10.1007\/s12350-021-02697-5.","journal-title":"J Nucl Cardiol."},{"key":"6125_CR24","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2967\/jnumed.108.060020","volume":"50","author":"SS Gambhir","year":"2009","unstructured":"Gambhir SS, Berman DS, Ziffer J, Nagler M, Sandler M, Patton J, et al. A novel high-sensitivity rapid-acquisition single-photon cardiac imaging camera. J Nucl Med. 2009;50:635\u201343. https:\/\/doi.org\/10.2967\/jnumed.108.060020.","journal-title":"J Nucl Med."},{"key":"6125_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12350-009-9052-6","volume":"16","author":"PJ Slomka","year":"2009","unstructured":"Slomka PJ, Patton JA, Berman DS, Germano G. Advances in technical aspects of myocardial perfusion SPECT imaging. J Nucl Cardiol. 2009;16:255\u201376. https:\/\/doi.org\/10.1007\/s12350-009-9052-6.","journal-title":"J Nucl Cardiol."},{"key":"6125_CR26","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1007\/s12350-020-02252-8","volume":"28","author":"L Liu","year":"2021","unstructured":"Liu L, Abdu FA, Yin G, Xu B, Mohammed A-Q, Xu S, et al. Prognostic value of myocardial perfusion imaging with D-SPECT camera in patients with ischemia and no obstructive coronary artery disease (INOCA). J Nucl Cardiol. 2021;28:3025\u201337. https:\/\/doi.org\/10.1007\/s12350-020-02252-8.","journal-title":"J Nucl Cardiol."},{"key":"6125_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00259-022-05948-w","volume":"50","author":"T Mannarino","year":"2022","unstructured":"Mannarino T, D\u2019Antonio A, Assante R, Zampella E, Gaudieri V, Buongiorno P, et al. Regional myocardial perfusion imaging in predicting vessel-related outcome: interplay between the perfusion results and angiographic findings. Eur J Nucl Med Mol Imaging. 2022;50:160\u20137. https:\/\/doi.org\/10.1007\/s00259-022-05948-w.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"6125_CR28","doi-asserted-by":"publisher","first-page":"827231","DOI":"10.3389\/fcvm.2022.827231","volume":"9","author":"H Zhang","year":"2022","unstructured":"Zhang H, Shi K, Fei M, Fan X, Liu L, Xu C, et al. A left ventricular mechanical dyssynchrony-based nomogram for predicting major adverse cardiac events risk in patients with ischemia and no obstructive coronary artery disease. Front Cardiovasc Med. 2022;9:827231. https:\/\/doi.org\/10.3389\/fcvm.2022.827231.","journal-title":"Front Cardiovasc Med."},{"key":"6125_CR29","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/eurheartj\/eht513","volume":"35","author":"F Crea","year":"2014","unstructured":"Crea F, Camici PG, Bairey Merz CN. Coronary microvascular dysfunction: an update. Eur Heart J. 2014;35:1101\u201311. https:\/\/doi.org\/10.1093\/eurheartj\/eht513.","journal-title":"Eur Heart J."},{"key":"6125_CR30","doi-asserted-by":"publisher","unstructured":"Ruddy TD, Tavoosi A, Taqueti VR. Role of nuclear cardiology in diagnosis and risk stratification of coronary microvascular disease.\u00a0J Nucl Cardiol. 2022. https:\/\/doi.org\/10.1007\/s12350-022-03051-z.","DOI":"10.1007\/s12350-022-03051-z"},{"key":"6125_CR31","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1007\/s12350-018-1448-8","volume":"26","author":"AG Monroy-Gonzalez","year":"2019","unstructured":"Monroy-Gonzalez AG, Tio RA, de Groot JC, Boersma HH, Prakken NH, De Jongste MJL, et al. Long-term prognostic value of quantitative myocardial perfusion in patients with chest pain and normal coronary arteries. J Nucl Cardiol. 2019;26:1844\u201352. https:\/\/doi.org\/10.1007\/s12350-018-1448-8.","journal-title":"J Nucl Cardiol."},{"key":"6125_CR32","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1161\/CIRCULATIONAHA.113.008507","volume":"129","author":"VL Murthy","year":"2014","unstructured":"Murthy VL, Naya M, Taqueti VR, Foster CR, Gaber M, Hainer J, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129:2518\u201327. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.008507.","journal-title":"Circulation."},{"key":"6125_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10554-020-01962-x","volume":"37","author":"Z Pang","year":"2021","unstructured":"Pang Z, Wang J, Li S, Chen Y, Wang X, Li J. Diagnostic analysis of new quantitative parameters of low-dose dynamic myocardial perfusion imaging with CZT SPECT in the detection of suspected or known coronary artery disease. Int J Cardiovasc Imaging. 2021;37:367\u201378. https:\/\/doi.org\/10.1007\/s10554-020-01962-x.","journal-title":"Int J Cardiovasc Imaging."},{"key":"6125_CR34","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2967\/jnumed.111.101840","volume":"53","author":"M Fiechter","year":"2012","unstructured":"Fiechter M, Ghadri JR, Gebhard C, Fuchs TA, Pazhenkottil AP, Nkoulou RN, et al. Diagnostic value of 13 N-ammonia myocardial perfusion PET: added value of myocardial flow reserve. J Nucl Med. 2012;53:1230\u20134. https:\/\/doi.org\/10.2967\/jnumed.111.101840.","journal-title":"J Nucl Med."},{"key":"6125_CR35","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.jacc.2014.05.069","volume":"64","author":"I Danad","year":"2014","unstructured":"Danad I, Uusitalo V, Kero T, Saraste A, Raijmakers PG, Lammertsma AA, et al. Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease. J Am Coll Cardiol. 2014;64:1464\u201375. https:\/\/doi.org\/10.1016\/j.jacc.2014.05.069.","journal-title":"J Am Coll Cardiol."},{"key":"6125_CR36","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s12350-020-02264-4","volume":"29","author":"MT Freitag","year":"2022","unstructured":"Freitag MT, Bremerich J, Wild D, Haaf P, Zellweger MJ, Caobelli F. Quantitative myocardial perfusion 82Rb-PET assessed by hybrid PET\/coronary-CT: normal values and diagnostic performance. J Nucl Cardiol. 2022;29:464\u201373. https:\/\/doi.org\/10.1007\/s12350-020-02264-4.","journal-title":"J Nucl Cardiol."},{"key":"6125_CR37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/ehjci\/jez258","volume":"21","author":"MJ Bom","year":"2020","unstructured":"Bom MJ, van Diemen PA, Driessen RS, Everaars H, Schumacher SP, Wijmenga J-T, et al. Prognostic value of [15O]H2O positron emission tomography-derived global and regional myocardial perfusion. Eur Heart J - Cardiovasc Imaging. 2020;21:777\u201386. https:\/\/doi.org\/10.1093\/ehjci\/jez258.","journal-title":"Eur Heart J - Cardiovasc Imaging."},{"key":"6125_CR38","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/ehjci\/jet068","volume":"14","author":"H Farhad","year":"2013","unstructured":"Farhad H, Dunet V, Bachelard K, Allenbach G, Kaufmann PA, Prior JO. Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging. Eur Heart J - Cardiovasc Imaging. 2013;14:1203\u201310. https:\/\/doi.org\/10.1093\/ehjci\/jet068.","journal-title":"Eur Heart J - Cardiovasc Imaging."},{"key":"6125_CR39","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00259-015-3163-x","volume":"43","author":"S Tuffier","year":"2016","unstructured":"Tuffier S, Legallois D, Belin A, Joubert M, Bailliez A, Redonnet M, et al. Assessment of endothelial function and myocardial flow reserve using 15O-water PET without attenuation correction. Eur J Nucl Med Mol Imaging. 2016;43:288\u201395. https:\/\/doi.org\/10.1007\/s00259-015-3163-x.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"6125_CR40","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2967\/jnumed.109.070748","volume":"51","author":"M Lubberink","year":"2010","unstructured":"Lubberink M, Harms HJ, Halbmeijer R, de Haan S, Knaapen P, Lammertsma AA. Low-dose quantitative myocardial blood flow imaging using 15 O-water and PET without attenuation correction. J Nucl Med. 2010;51:575\u201380. https:\/\/doi.org\/10.2967\/jnumed.109.070748.","journal-title":"J Nucl Med."},{"key":"6125_CR41","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10741-017-9625-4","volume":"22","author":"F Al Badarin","year":"2017","unstructured":"Al Badarin F, Aljizeeri A, Almasoudi F, Al-Mallah MH. Assessment of myocardial blood flow and coronary flow reserve with positron emission tomography in ischemic heart disease: current state and future directions. Heart Fail Rev. 2017;22:441\u201353. https:\/\/doi.org\/10.1007\/s10741-017-9625-4.","journal-title":"Heart Fail Rev."},{"key":"6125_CR42","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jcmg.2021.09.030","volume":"15","author":"R Liga","year":"2022","unstructured":"Liga R, Neglia D, Kusch A, Favilli B, Giorgetti A, Gimelli A. Prognostic role of dynamic CZT imaging in CAD patients. JACC Cardiovasc Imaging. 2022;15:540\u20132. https:\/\/doi.org\/10.1016\/j.jcmg.2021.09.030.","journal-title":"JACC Cardiovasc Imaging."},{"key":"6125_CR43","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/ehjci\/jet274","volume":"15","author":"E Joutsiniemi","year":"2014","unstructured":"Joutsiniemi E, Saraste A, Pietila M, Maki M, Kajander S, Ukkonen H, et al. Absolute flow or myocardial flow reserve for the detection of significant coronary artery disease? Eur Heart J - Cardiovasc Imaging. 2014;15:659\u201365. https:\/\/doi.org\/10.1093\/ehjci\/jet274.","journal-title":"Eur Heart J - Cardiovasc Imaging."},{"key":"6125_CR44","doi-asserted-by":"publisher","unstructured":"Zampella E, Mannarino T, D\u2019Antonio A, Assante R, Gaudieri V, Buongiorno P, et al. Prediction of outcome by 82Rb PET\/CT in patients with ischemia and nonobstructive coronary arteries. J Nucl Cardiol. 2022.\u00a0https:\/\/doi.org\/10.1007\/s12350-022-03144-9.","DOI":"10.1007\/s12350-022-03144-9"},{"issue":"12","key":"6125_CR45","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1161\/CIRCULATIONAHA.114.012636","volume":"131","author":"B-K Lee","year":"2015","unstructured":"Lee B-K, Lim H-S, Fearon WF, Yong AS, Yamada R, Tanaka S, et al. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation. 2015;131(12):1054\u201360. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.012636.","journal-title":"Circulation."},{"issue":"12","key":"6125_CR46","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1161\/CIRCULATIONAHA.115.015553","volume":"131","author":"CJ Pepine","year":"2015","unstructured":"Pepine CJ. Multiple causes for ischemia without obstructive coronary artery disease: not a short list. Circulation. 2015;131(12):1044\u20136. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.015553.","journal-title":"Circulation."},{"key":"6125_CR47","doi-asserted-by":"publisher","unstructured":"de Souza AC do AH, Harms HJ, Martell L, Bibbo C, Harrington M, Sullivan K, et al. Accuracy and reproducibility of myocardial blood flow quantification by single photon emission computed tomography imaging in patients with known or suspected coronary artery disease. Circ Cardiovasc Imaging. 2022;15(6):e013987. https:\/\/doi.org\/10.1161\/CIRCIMAGING.122.013987.","DOI":"10.1161\/CIRCIMAGING.122.013987"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06125-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06125-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06125-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:02:56Z","timestamp":1684540976000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06125-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["6125"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06125-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]},"assertion":[{"value":"7 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Shanghai Tenth People\u2019s Hospital (No. SHSY-IEC-4.1\/21-126\/01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for the publication of the images in Fig.\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}